Venza I - Search Results

1

Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.

Venza M, Visalli M, Beninati C, Biondo C, Teti D, Venza I. Venza M, et al. Among authors: venza i. Anticancer Agents Med Chem. 2016;16(5):528-38. doi: 10.2174/1871520615666150803124139. Anticancer Agents Med Chem. 2016. PMID: 26234362 Review.

2

Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.

Venza M, Visalli M, Biondo C, Lentini M, Catalano T, Teti D, Venza I. Venza M, et al. Among authors: venza i. Biochim Biophys Acta. 2015 Mar;1849(3):247-56. doi: 10.1016/j.bbagrm.2014.12.004. Epub 2014 Dec 11. Biochim Biophys Acta. 2015. PMID: 25497382

3

The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma.

Venza M, Visalli M, Oteri R, Agliano F, Morabito S, Teti D, Venza I. Venza M, et al. Among authors: venza i. Int Immunopharmacol. 2015 Sep;28(1):313-21. doi: 10.1016/j.intimp.2015.06.024. Epub 2015 Jun 27. Int Immunopharmacol. 2015. PMID: 26122536

4

IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.

Venza I, Visalli M, Beninati C, Benfatto S, Teti D, Venza M. Venza I, et al. Among authors: venza m. BMC Med Genomics. 2015 Dec 3;8:81. doi: 10.1186/s12920-015-0156-3. BMC Med Genomics. 2015. PMID: 26631117 Free PMC article.

5

Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma.

Venza M, Visalli M, Catalano T, Beninati C, Teti D, Venza I. Venza M, et al. Among authors: venza i. Anticancer Agents Med Chem. 2017;17(2):190-205. doi: 10.2174/1871520616666160425110401. Anticancer Agents Med Chem. 2017. PMID: 27109020 Review.

6

Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.

Venza M, Visalli M, Catalano T, Fortunato C, Oteri R, Teti D, Venza I. Venza M, et al. Among authors: venza i. Biochem Biophys Res Commun. 2013 Nov 29;441(4):743-50. doi: 10.1016/j.bbrc.2013.10.114. Epub 2013 Nov 5. Biochem Biophys Res Commun. 2013. PMID: 24211571

7

Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines.

Venza M, Dell'Aversana C, Visalli M, Altucci L, Teti D, Venza I. Venza M, et al. Among authors: venza i. Tumori. 2014 Jan-Feb;100(1):e4-7. doi: 10.1700/1430.15828. Tumori. 2014. PMID: 24675509

8

Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP.

Venza I, Visalli M, Oteri R, Teti D, Venza M. Venza I, et al. Among authors: venza m. Int Immunopharmacol. 2014 Aug;21(2):439-46. doi: 10.1016/j.intimp.2014.05.024. Epub 2014 Jun 2. Int Immunopharmacol. 2014. PMID: 24946096

9

Epigenetic marks responsible for cadmium-induced melanoma cell overgrowth.

Venza M, Visalli M, Biondo C, Oteri R, Agliano F, Morabito S, Teti D, Venza I. Venza M, et al. Among authors: venza i. Toxicol In Vitro. 2015 Feb;29(1):242-50. doi: 10.1016/j.tiv.2014.10.020. Toxicol In Vitro. 2015. PMID: 25448810

10

Involvement of epimutations in meningioma.

Venza M, Visalli M, Beninati C, Catalano T, Biondo C, Teti D, Venza I. Venza M, et al. Among authors: venza i. Brain Tumor Pathol. 2015 Jul;32(3):163-8. doi: 10.1007/s10014-015-0221-9. Epub 2015 May 1. Brain Tumor Pathol. 2015. PMID: 25930103 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters